Abella, Bb Girl .

HRN: 21-46-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2022
AMPICILLIN 250MG (VIAL)
06/15/2022
06/21/2022
IVT
130mg
Q12 For 7 Days
Bloodstream
Waiting Final Action 
06/15/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/15/2022
06/21/2022
IVT
13mg
Q24 For 7 Days
Bloodstream
Waiting Final Action 
11/16/2022
CEFUROXIME 750MG (VIAL)
11/16/2022
11/23/2022
IV
175mg
Q8
Age With Mod Dhn
Waiting Final Action 
11/16/2022
AMPICILLIN 1GM (VIAL)
11/16/2022
11/23/2022
IV
265mg
Q12
Age With Mod Dhn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: